Business

Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases

Financial Post · August 24, 2026 at 10:30 a.m.

SALT LAKE CITY, Aug.

24, 2026 (GLOBE NEWSWIRE) -- Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Unit (NAMRU) EURAFCENT, part of Navy Medicine Research & Development that is focused on infectious disease threats affecting military personnel, to evaluate SeekIt™, the company’s instrument-free molecular diagnostic platform.

SeekIt includes a field kit and single-use device for detecting infectious diseases in forward-deployed, austere, and resource-constrained settings.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases

More from Financial Post

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 2026

Snow Alert: It’s Snowing in Ikon Pass Country

William Watson: Let’s see the last draft. Inquiring voters want to know

Opinion: We need to reduce wildfire fuel and zone better

More in Business

New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 2026

Snow Alert: It’s Snowing in Ikon Pass Country

Old soup factory takes on new high-tech life as quantum computing firm gets $195M federal boost

William Watson: Let’s see the last draft. Inquiring voters want to know

Opinion: We need to reduce wildfire fuel and zone better

Zacatecas Silver Closes the Second Tranche of Non-Brokered Private Placement